Table 3.
Authors | Study characteristics | Control group | Measurement of anxiety disorders | Rates of anxiety disorders |
---|---|---|---|---|
Petrushkin, Boardman, & Ovuga, 2005 | n = 46 Ugandans, 52.2% female, mean age = 36.6 | None | MINI International Neuropsychiatric Interview (MINI1) | 32.6% met criteria for panic disorder, 23.9% met criteria for panic with agoraphobia, 10.9% for social anxiety disorder, and 4.3% for OCD |
Olley, Seedat, Nei, & Stein, 2004 | n = 149 HIV+ individuals living in South Africa; 70% female, mean age = 30 | None | MINI1 | 14.8% of participants met criteria for PTSD, and 6.7% met criteria for GAD |
Adewuya et al., 2007 | n = 88 HIV+ individuals living in Nigeria newly diagnosed with HIV (first seropositive test < 1 month prior) | 87 seronegative controls matched on age, sex, andsocioeconomic status | MINI1 | 34.1% of HIV+ participants met criteria for any anxiety disorder, compared to 12.5% of controls (Odds Ratio = 3.57; CI = 1.657.72) |
Spies et al., 2009 | n = 429 HIV+ individuals living in South Africa; 67% Xhosa speaking, 25% Afrikaans speaking, 8% English speaking | None | K-102 and MINI1 | 15.3% met criteria for panic disorder, 18.4% agoraphobia, 12.3% social phobia, 21.5% PTSD, and 18.4% GAD |
Marwick & Kaaya, 2010 | n = 220 HIV+ persons living in Tanzania, 74% female, mean age = 41 | None | Clinical Interview Schedule-Revised (CIS-R3) | 12.7% of participants met criteria for mixed anxiety and depression, 3.2% for a specific phobia, 1.8% for panic disorder, and 0.9% for OCD |
Campos, Guimaraes, & Remien, 2010 | n = 293 HIV+ individuals living in Brazil; 65.9% male, 52.9% under age 35 | None | HADS4 | 35.8% of participants met criteria for moderate and severe anxiety, indicating an anxiety disorder |
Sivasubramanian et al., 2011 | n = 150 HIV+ men who have sex with men in Mumbai, India | None | MINI1 | 24% met criteria for any anxiety disorder |
Nebhinani, Mattoo, & Wanchu, 2011 | n = 100 HIV+ individuals living in India; 59% male, mean age = 33.6 | 40 patients with rheumatoid arthritis | Structured Clinical Interview for the DSM-IV Clinician Version (SCID-CV5) | 1% of participants with HIV met criteria for panic disorder; 2.5% of participants with RA met criteria for panic disorder |
Hasanah, Zaliha, & Mahiran, 2011 | n = 271 PLWHA in Malaysia, 57.6% male, 60.1% between ages 30–39 | None | HADS4 | 29% of the sample met criteria for a “probable anxiety disorder” |
Olagunju, Adeyemi, Ogbolu, & Campbell, 2012 | n = 300 HIV+ individuals living with HIV in Lagos, Nigeria; 38.7% male, mean age = 36.95 | None | Schedule for Clinical Assessment in Neuropsychiatry (SCAN6) | 21.7% of the sample met criteria for an anxiety disorder, including 4% for social anxiety disorder, 1.7% for panic disorder, and 6.2% for “anxiety disorder unspecified” |
Breuer et al., 2014 | n = 366 HIV+ individuals living in South Africa; 71% female, mean age = 32.7 | None | Substance and Mental Illness Symptom Screener (SAMISS7) and Mini International Neuropsychiatric Interview (MINI1) | 3% of the sample met criteria for an anxiety disorder |
MINI International Neuropsychiatric Interview (MINI; Sheehan et al., 1998);
K-10, Kessler et al., 2002;
Clinical Interview Schedule-Revised (CIS-R; Lewis, Pelosi, Araya, Dunn, 1992);
Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983);
Structured Clinical Interview for the DSM-IV Clinician Version (SCID-CV; First, Spitzer, Gibbon, & Williams, 1997);
Schedule for Clinical Assessment in Neuropsychiatry (SCAN; World Health Organization, 1995);
Substance and Mental Illness Symptom Screener (SAMISS; Pence et al., 2005).